Minimal Residual Disease in Colorectal Cancer: Establishing Clinical Utility, Course #25D12 - 10/18/2024

Friday, October 18, 2024, 8:00 AM - 9:00 AM, Zoom Videoconference, Oklahoma City, OK

NOTE: The meeting host will admit you to the meeting no earlier than 15 minutes before the scheduled start time. If you login early then please wait for the host to admit you. 
Attending a Zoom meeting:
If you have not yet attended a Zoom meeting then please visit this site (below) for information you will need:
https://support.zoom.us/hc/en-us/articles/201362193-Joining-a-Meeting

1. Utilize new approaches in recently approved cancer therapies
2. Make use of the advances in evaluation and diagnosis in addition to management of immune therapies and cellular therapies in cancer patients.
3. Employ recent diagnostic technologies in daily practice.

Accreditation Statement: The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

The University of Oklahoma is an equal opportunity institution. www.ou.edu/eoo

Accommodation Statement: For accommodations on the basis of disability, contact Robin Vinson: 271-4022 ext. 48342 or [email protected].

Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma ("OU") nor does OU provide any warranty as to their accuracy or reliability. 

Policy on Planner and Presenter Disclosure: It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also discloses discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.

Commercial support is financial, or in-kind, contributions given by an ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is any company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 
This activity received no commercial or in-kind support.